Original document(9 pages) Authorized document(10 pages) 中文版
    The present ivnention relates to medicine. Lilac leaf is decocted for 2-3 times of 1-3 hr each; the merged decoction is filtered; the filtrate is adsorbed in macro porous resin, water washed to become color-less, and 50-88% ethanol eluted to collect the eluted liquid while recovering ethanol; and the eluted liquid is concentrated and dried to obtain the syringic total saponin extractive. The syringic total saponin extractive is yellow or deep orange bitter powder and accounts for 3-7 wt% of dry lilac leaf. The medicine composition containing syringic total saponin extractive as active component is used in treating hepatosis and protecting liver.
Application Number
申请号
02133204 Application Date
申请日
2002.10.17
Title 名称 Syringic general saponin extractive and its prepn and medicinal composition
Publication Number
公开号
1403466 Publication Date
公开日
2003.03.19
Approval Pub. Date Granted Pub. Date 2004.10.20
International Classification 分类号 A61K31/70,A61K35/78,A61P1/16,C07H1/08
Applicant(s) Name
申请人
Li Pingya
Address 地址 130021
Inventor(s) Name 发明人 Li Pingya, Lu Dan
Attorney & Agent 代理人
More information 更  多  信  息


 Related patents information
Use of total polygalin in preparing medicine for promoting gastrointestinal peristalsis
Process for extracting ginsenoside Re, and use of medicine thereof
Semisynthesizing method for 20(S)-ginsenoside Rg3, and use in medicine
Pseudo gensenoside-Pgq and its semi-synthesis and medicinal use
Extract of american ginseng fruit saponin, extracting and refining method and medicinal use thereof
Application of ginsenoside Re for preparing medicine for curing dysmnesia
Semi-synthesis method of 20(s)-ginsenoside Rg2
Herminium's triochistisaponine extract and its extraction refining method and its medical use
Pseudoginsenoside Pdq and its semi-synthesis process and medicine use
Total saponin extract of dioscorea nipponica stem and leaf and its extraction process and medicine use
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.